4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-019804
Chief Development Officer sold 2,810 shares at $8.28 ($23,267)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaiser Peter · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-23 | Sale : show line 1 in the form 10b5-1 | −2,810 | $8.28 | $23,267 | 269,108 | D |
| Open-market sales · 2,810 sh · avg $8.28 · $23,267 | ||||||
Loading xslF345X05/tm267255-3_4seq1.xml…